What is the Impact Factor of Stem Cell Research & Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Stem Cell Research & Therapy is 7.80, ranking in quartile Q1 of Web of Science (SCIE).

Is Stem Cell Research & Therapy indexed in Web of Science or Scopus?

Yes, Stem Cell Research & Therapy is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.939 (Q1) and an H-index of 150.

Who publishes Stem Cell Research & Therapy and what is the Article Processing Charge (APC)?

Stem Cell Research & Therapy is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $3,678 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Stem Cell Research & Therapy?

The official ISO-4 abbreviation of Stem Cell Research & Therapy is "STEM CELL RES. THER" with common acronym "scrt". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,535Top JournalGold OA

Stem Cell Research & Therapy

Acronym:scrt

•

Abbreviation (ISO):STEM CELL RES. THER

•

Identifier (ISSN):1757-6512(Print)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

7.8↑ +0.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Stem Cell Research & Therapy

WoS Q1

Annual Impact Factor Metric

Current (2026):7.8

Scopus SJR & RankScopus Q1

1.939

#1,535

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

150

150 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate4.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

584articles/year

100% Gold OA•77.33% Original Research

Aims & Scope

Stem Cell Research & Therapy is the major forum for translational research into stem cell therapies. An international peer-reviewed journal, it publishes high-quality open access research articles with a special emphasis on basic, translational and clinical research into stem cell therapeutics and regenerative therapies, including animal models and clinical trials. The journal also provides reviews, viewpoints, commentaries and reports.

Topics Covered (Recognized by AI)

Biology99.5%Genetics98.4%Cell biology96.1%Medicine94.6%Chemistry88.2%Biochemistry86.5%Stem cell84.1%Internal medicine80.6%Pathology74%Mesenchymal stem cell57.9%Immunology52.4%Gene52.3%Cancer research39.9%In vitro39.7%Endocrinology35.9%Surgery35.6%Cell31.5%Transplantation23%Embryonic stem cell21.6%

Primary Research Areas

Cell Biology Medicine Research & Experimental

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CELL & TISSUE ENGINEERING

Rank4/32

IndexSCIE

JCRSCIE2026

CELL BIOLOGY

Rank42/207

IndexSCIE

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank28/191

IndexSCIE

JCISCIE2026

CELL & TISSUE ENGINEERING

Rank6/32

IndexSCIE

JCISCIE2026

CELL BIOLOGY

Rank36/207

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank32/191

IndexSCIE

Category	Index	Rank	Quartile
CELL & TISSUE ENGINEERING	JCRSCIE	4/32	Q1
CELL BIOLOGY	JCRSCIE	42/207	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	28/191	Q1
CELL & TISSUE ENGINEERING	JCISCIE	6/32	Q1
CELL BIOLOGY	JCISCIE	36/207	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	32/191	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF7.8

Articles / Year419

Total Citations196

2025

IF7.3

Articles / Year763

Total Citations5,162

2024

IF7.1

Articles / Year505

Total Citations7,184

2023

IF7.5

Articles / Year383

Total Citations8,615

2022

IF8.079

Articles / Year536

Total Citations19,116

Year	Impact Factor	Articles / Year	Total Citations
2026	7.8	419	196
2025	7.3	763	5,162
2024	7.1	505	7,184
2023	7.5	383	8,615
2022	8.079	536	19,116
2021	6.832	609	26,419
2020	5.116	533	29,398
2019	4.627	408	29,426
2018	4.963	358	23,904
2017	—	292	19,880
2016	—	191	13,175
2015	—	264	16,983

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,535Scopus Q1SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.939

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

7.40

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,678 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations11,394

3-Year Documents1,357

Citable Documents1,341

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1

Cell BiologyQ1

Medicine (miscellaneous)Q1

Molecular MedicineQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

2区CELL & TISSUE ENGINEERING

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Stem Cell Research & Therapy (acronym: scrt, abbr: STEM CELL RES. THER, ISSN: 1757-6512) is a peer-reviewed international scholarly journal in the field of CELL BIOLOGY, published by BioMed Central in England since 2010. The periodical holds a Journal Impact Factor (JIF) of 7.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.939 (Q1), an H-index of 150.

The journal enforces rigorous peer evaluation with an annual output of approximately 584 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,678 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.